Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain.

Exclusion Criteria

• •The subject will be excluded if she:
• •Is pregnant or breast feeding or is planning a pregnancy within the duration of the treatment period of the study.
• •Is less than 6 months postpartum or 3 months postabortion/ miscarriage at the time of entry into the screening period.
• •Has had a surgical history of any major abdominal surgery within 6 months or any interventional surgery for endometriosis performed within a period of 2 months before screening.
• •Did not respond to prior treatment with GnRH agonists or GnRH antagonists for endometriosis.
• •Has a history of, or known, osteoporosis or other metabolic bone disease.
• •Has chronic pelvic pain that is not caused by endometriosis and requires chronic analgesic or other chronic therapy which would interfere with the assessment of endometriosis-associated pain.